Huntington National Bank’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58K | Buy |
673
+128
| +23% | +$11.5K | ﹤0.01% | 1288 |
|
|
2025
Q4 | $47.6K | Sell |
545
-44
| -7% | -$3.34K | ﹤0.01% | 1267 |
|
|
2025
Q3 | $33.7K | Sell |
589
-153
| -21% | -$8.81K | ﹤0.01% | 1421 |
|
|
2025
Q2 | $43.8K | Buy |
742
+136
| +22% | +$8.79K | ﹤0.01% | 1288 |
|
|
2025
Q1 | $44.4K | Sell |
606
-352
| -37% | -$29.1K | ﹤0.01% | 1232 |
|
|
2024
Q4 | $79.2K | Buy |
958
+310
| +48% | +$24.4K | ﹤0.01% | 1015 |
|
|
2024
Q3 | $46.4K | Buy |
648
+87
| +16% | +$6.14K | ﹤0.01% | 1206 |
|
|
2024
Q2 | $38.4K | Buy |
561
+23
| +4% | +$1.37K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $28.9K | Buy |
538
+27
| +5% | +$1.45K | ﹤0.01% | 1342 |
|
|
2023
Q4 | $27.2K | Sell |
511
-16
| -3% | -$780 | ﹤0.01% | 1328 |
|
|
2023
Q3 | $26.2K | Buy |
527
+35
| +7% | +$1.96K | ﹤0.01% | 1265 |
|
|
2023
Q2 | $29.3K | Buy |
492
+50
| +11% | +$2.85K | ﹤0.01% | 1242 |
|
|
2023
Q1 | $25K | Sell |
442
-2
| -0.5% | -$128 | ﹤0.01% | 1238 |
|
|
2022
Q4 | $33K | Buy |
444
+7
| +2% | +$477 | ﹤0.01% | 1120 |
|
|
2022
Q3 | $26K | Hold |
437
| – | – | ﹤0.01% | 1191 |
|
|
2022
Q2 | $25K | Buy |
437
+261
| +148% | +$17.2K | ﹤0.01% | 1237 |
|
|
2022
Q1 | $13K | Buy |
176
+17
| +11% | +$1.18K | ﹤0.01% | 1500 |
|
|
2021
Q4 | $11K | Buy |
+159
| New | +$11.5K | ﹤0.01% | 1551 |
|
|
2019
Q1 | – | Sell |
-879
| Closed | -$38K | – | 1639 |
|
|
2018
Q4 | $38K | Buy |
+879
| New | +$43.9K | ﹤0.01% | 941 |
|
|
2018
Q1 | – | Sell |
-3,429
| Closed | -$141K | – | 1604 |
|
|
2017
Q4 | $141K | Hold |
3,429
| – | – | ﹤0.01% | 668 |
|
|
2017
Q3 | $102K | Buy |
3,429
+882
| +35% | +$26.9K | ﹤0.01% | 766 |
|
|
2017
Q2 | $84K | Hold |
2,547
| – | – | ﹤0.01% | 803 |
|
|
2017
Q1 | $75K | Hold |
2,547
| – | – | ﹤0.01% | 824 |
|
|
2016
Q4 | $63K | Hold |
2,547
| – | – | ﹤0.01% | 864 |
|
|
2016
Q3 | $57K | Sell |
2,547
-2,867
| -53% | -$67.4K | ﹤0.01% | 891 |
|
|
2016
Q2 | $129K | Sell |
5,414
-891
| -14% | -$21.4K | ﹤0.01% | 669 |
|
|
2016
Q1 | $159K | Buy |
6,305
+280
| +5% | +$6.84K | ﹤0.01% | 740 |
|
|
2015
Q4 | $168K | Sell |
6,025
-297
| -5% | -$7.46K | ﹤0.01% | 660 |
|
|
2015
Q3 | $131K | Buy |
6,322
+104
| +2% | +$2.63K | ﹤0.01% | 768 |
|
|
2015
Q2 | $160K | Sell |
6,218
-87
| -1% | -$2.2K | ﹤0.01% | 749 |
|
|
2015
Q1 | $159K | Buy |
6,305
+2,504
| +66% | +$61K | ﹤0.01% | 745 |
|
|
2014
Q4 | $90K | Buy |
+3,801
| New | +$84.2K | ﹤0.01% | 949 |
|
Other funds holding GMED
VCM
VPM
SC
Huntington National Bank's GMED Position: Q1 2026 in Review
Huntington National Bank increased its Globus Medical (GMED) stake by 23% in Q1 2026, buying an estimated $11.5K and bringing the position to 673 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.
Huntington National Bank first reported a position in GMED in Q4 2014 and has held it in 32 quarters since. The position peaked at $168K in Q4 2015. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Huntington National Bank held 673 shares of Globus Medical worth $58K as of Q1 2026.
- Huntington National Bank bought 128 Globus Medical shares in Q1 2026, an estimated $11.5K.
- Globus Medical made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1288 holding.
- Huntington National Bank first reported a position in Globus Medical in Q4 2014 and has held it in 32 quarters since.
- Huntington National Bank's Globus Medical position peaked at $168K in Q4 2015.
- 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.